Related Experiment Video
Updated: Oct 1, 2025

11:38
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
12.4K
Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a
Susan P Felter1, Virunya S Bhat2, Philip A Botham3
1Procter & Gamble, Mason, OH, USA.
Critical Reviews in Toxicology
|March 3, 2022
Summary
This workshop explored challenges in chemical carcinogenicity assessment, highlighting the need for integrated New Approach Methodologies (NAMs) to improve hazard identification and risk evaluation.
Area of Science:
- Toxicology
- Chemical Carcinogenicity
- Risk Assessment
Background:
- An international workshop addressed challenges in chemical carcinogenicity assessment.
- Key topics included modes-of-action, dose-response, and New Approach Methodologies (NAMs).
Purpose of the Study:
- To identify challenges and knowledge gaps in chemical carcinogenicity assessment.
- To explore the integration of NAMs into hazard identification and risk assessment.
- To propose a framework for advancing carcinogenicity risk assessment.
Main Methods:
- Convened an international state-of-the-science workshop.
- Organized discussions around problem formulation, modes-of-action, dose-response, and NAMs.
- Developed a decision matrix for carcinogenicity assessment.
Main Results:
- Acknowledged limitations of traditional rodent bioassays.
- Identified knowledge gaps for the development and uptake of NAMs.
- Highlighted the need for integrated and defined approaches for testing and assessment.
Conclusions:
- Single NAMs are unlikely to replace traditional bioassays; integrated approaches are needed.
- Adverse outcome pathway networks can aid evidence organization.
- A decision matrix was proposed to guide carcinogenicity assessment.
Keywords:
Adverse outcome pathway (AOP)cancer bioassay (OECD TG 453)decision matrixdefined approach (DA)genotoxic carcinogenicityhazard classificationintegrated approach to testing and assessment (IATA)kinetically derived maximum dose (KMD)mode-of-action (MoA)new approach methodologies (NAM)non-genotoxic carcinogenicitypoint of departure (PoD)risk assessmentrodent chronic bioassayweight of evidence (WoE)Related Concept Videos
Mutagenicity and Carcinogenicity
1.5K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Types of Toxins
2.1K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.1K
Effects of Chemicals: Overview
1.5K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.5K
Hazard Ratio
278
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
278
Criteria for Causality: Bradford Hill Criteria - II
743
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
743

